CFO  News Hubb
Advertisement
  • Home
  • CFO News
  • Financial Advisor
  • Financial Planning
  • Markets News
  • Economics
  • Contact
No Result
View All Result
  • Home
  • CFO News
  • Financial Advisor
  • Financial Planning
  • Markets News
  • Economics
  • Contact
No Result
View All Result
CFO  News Hubb
No Result
View All Result
Home Markets News

Snap, Apple, Boeing and more

by admin
March 6, 2023
in Markets News
Snap, Apple, Boeing and more


Check out the companies making headlines in midday trading.

An Apple store on Nanjing Road Pedestrian Street in Shanghai, China, on December 16, 2022.

CFOTO | Future Publishing | Getty Images

Snap — The tech company’s shares gained almost 13%, having their strongest day since November. Shares gained as U.S. lawmakers prepare legislation that would give President Joe Biden the authority to ban TikTok, one of Snapchat’s primary competitors.

Apple — Shares advanced more than 3% after Goldman Sachs initiated coverage of the big technology stock as a buy. The firm said Apple could get boosted by its services business.

Credit Suisse — Shares were down about 1% after former top shareholder Harris Associates sold its entire stake in Credit Suisse, according to a Financial Times report. Harris Associates CIO David Herro said there are questions about the future of the franchise and large outflows from its wealth management division.

Boeing — The aerospace company’s shares fell 1.6% following reports that software issues could delay deliveries of its MAX and 787 aircraft by up to a year.

RH — The furniture store, formerly known as Restoration Hardware, saw its stock dip more than 2% after Jefferies downgraded it to hold from buy. The Wall Street firm said the luxury housing market is struggling to stabilize, which will impact RH’s business.

Biomarin Pharmaceutical — Shares dropped by more than 6% after competitor BridgeBio Pharma reported positive trial data on its candidate for achondroplasia, the most common form of dwarfism, in children, which could challenge Biomarin’s Voxzogo medication. 

Emerson Electric — Shares rose about 3% following an upgrade by UBS to buy from neutral. The Wall Street firm said the derating of Emerson Electric is overdone.

Vir Biotechnology — The biotech stock added 1.4% following a JPMorgan upgrade to overweight from neutral. The firm said the company has a strong drug pipeline, specifically mentioning its trials for hepatitis B and the flu.

Domino’s Pizza — Domino’s Pizza shares advanced more than 4%. On Friday, Gordon Haskett downgraded the stock to hold from buy, and lowered its price target, saying the pizza chain will find it difficult to “easily drive a return to 6-10% average annual system sales growth.”

— CNBC’s Alex Harring, Yun Li, Sarah Min and Michelle Fox contributed reporting.



Source link

Previous Post

This is Why We Can’t Have Nice Things: Directionalists vs. Destinationists

Next Post

IBM’s Ginni Rometty on Skill-Building and Success

TRENDING

Stocks making the biggest moves premarket: BBBY, NKLA,VORB
Markets News

Stocks making the biggest moves premarket: BBBY, NKLA,VORB

April 1, 2023
Economics

Don’t Expand Deposit Insurance. Abolish It!

April 1, 2023
Economics

Announcing 2023 Water Cooler Fundraiser!

April 1, 2023
CFO News

‘I Went Through the Doggy Door.’ When Real-Estate Pros Get Locked Out of Listings

April 1, 2023
Financial Planning

What Is the Optimal Pattern of a Customer Journey?

April 1, 2023

©  CFO News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • CFO News
  • Financial Advisor
  • Financial Planning
  • Markets News
  • Economics
  • Contact

Newsletter Sign Up

No Result
View All Result
  • Home
  • CFO News
  • Financial Advisor
  • Financial Planning
  • Markets News
  • Economics
  • Contact

© 2022 CFO News Hubb All rights reserved.